Three-dimensional assembly of tissue-engineered cartilage constructs results in cartilaginous tissue formation without retainment of zonal characteristics

Journal of Tissue Engineering and Regenerative Medicine

Volumn 10, Issue 4, 2016, Pages 315-324

  Schuurman, W ^a,b   Harimulyo, E B ^a   Gawlitta, D ^a   Woodfield, T B F ^c   Dhert, W J A ^a,b   Van Weeren, P R ^b   Malda, J ^a  

^a UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^b UTRECHT UNIVERSITY   (Netherlands)

^c UNIVERSITY OF OTAGO   (New Zealand)

Author keywords

3D; Cartilage; Chondrocytes; Fibre deposition; Regenerative medicine; Scaffolds; Tissue engineering; Zonal

Indexed keywords

CELL CULTURE; CELL PROLIFERATION; EFFICIENCY; PELLETIZING; POLYETHYLENE GLYCOLS; REGENERATIVE MEDICINE; SCAFFOLDS (BIOLOGY);

3D; CARTILAGINOUS TISSUES; CHONDROCYTES; FIBER DEPOSITION; GLYCOSAMINOGLYCANS; REGENERATIVE MEDICINE; SEEDING EFFICIENCY; TISSUE FORMATION; TISSUES ENGINEERINGS; ZONAL;

CARTILAGE;

COLLAGEN TYPE 2; GLYCOSAMINOGLYCAN; MACROGOL; POLYBUTYLENE TEREPHTHALATE; TEREPHTHALIC ACID; BIOLOGICAL MARKER; COLLAGEN TYPE 1; DNA;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; ARTICULAR CARTILAGE; CARTILAGE CELL; CELL CULTURE; CELL POPULATION; CONTROLLED STUDY; HORSE; IN VITRO STUDY; NONHUMAN; PRIORITY JOURNAL; TISSUE ENGINEERING; TISSUE SCAFFOLD; ANIMAL; CHEMISTRY; HUMAN; IMMUNOHISTOCHEMISTRY; METABOLISM; PHYSIOLOGY; PROCEDURES;

ANIMALS; BIOMARKERS; CARTILAGE, ARTICULAR; CELLS, CULTURED; COLLAGEN TYPE I; COLLAGEN TYPE II; DNA; GLYCOSAMINOGLYCANS; HORSES; HUMANS; IMMUNOHISTOCHEMISTRY; TISSUE ENGINEERING; TISSUE SCAFFOLDS;

EID: 84876688374     PISSN: 19326254     EISSN: 19327005     Source Type: Journal    
DOI: 10.1002/term.1726     Document Type: Article

References (70)

1. Bernardo BC, Belluoccio D, Rowley L, et al. 2011; Cartilage intermediate layer protein 2 (CILP-2) is expressed in articular and meniscal cartilage and down-regulated in experimental osteoarthritis. J Biol Chem 286(43): 37758-37767.
2. Bhosale AM, Richardson JB. 2008; Articular cartilage: structure, injuries and review of management. Br Med Bull 87: 77-95.
3. Buckwalter JA, Mankin HJ. 1998; Articular cartilage: tissue design and chondrocyte-matrix interactions. Instr Course Lect 47: 477-486.
4. Chawla K, Klein TJ, Schumacher BL, et al. 2007; Short-term retention of labeled chondrocyte subpopulations in stratified tissue-engineered cartilaginous constructs implanted in vivo in mini-pigs. Tissue Eng 13(7): 1525-1537.
5. Cheuk YC, Wong MW, Lee KM, et al. 2011; Use of allogeneic scaffold-free chondrocyte pellet in repair of osteochondral defect in a rabbit model. J Orthop Res 29(9): 1343-1350.
6. Cohen DL, Malone E, Lipson H, et al. 2006; Direct freeform fabrication of seeded hydrogels in arbitrary geometries. Tissue Eng 12(5): 1325-1335.
7. Cui X, Breitenkamp K, Finn MG, et al. 2012; Direct human cartilage repair using three-dimensional bioprinting technology. Tissue Eng Part A 18(11-12): 1304-1312.
8. Darling EM, Athanasiou KA. 2005; Retaining zonal chondrocyte phenotype by means of novel growth environments. Tissue Eng 11(3-4): 395-403.
9. DiCesare PE, Morgelin M, Carlson CS, et al. 1995; Cartilage oligomeric matrix protein: isolation and characterization from human articular cartilage. J Orthop Res 13(3): 422-428.
10. Farndale RW, Buttle DJ, Barrett AJ. 1986; Improved quantitation and discrimination of sulphated glycosaminoglycans by use of dimethylmethylene blue. Biochim Biophys Acta 883(2): 173-177.
11. Fedorovich NE, Alblas J, de Wijn JR, et al. 2007; Hydrogels as extracellular matrices for skeletal tissue engineering: state-of-the-art and novel application in organ printing. Tissue Eng 13(8): 1905-1925.
12. Flannery CR, Hughes CE, Schumacher BL, et al. 1999; Articular cartilage superficial zone protein (SZP) is homologous to megakaryocyte stimulating factor precursor and is a multifunctional proteoglycan with potential growth-promoting, cytoprotective, and lubricating properties in cartilage metabolism. Biochem Biophys Res Commun 254(3): 535-541.
13. Fukui N, Miyamoto Y, Nakajima M, et al. 2008; Zonal gene expression of chondrocytes in osteoarthritic cartilage. Arthritis Rheum 58(12): 3843-3853.
14. Gao L, McBeath R, Chen CS. 2010; Stem cell shape regulates a chondrogenic versus myogenic fate through Rac1 and N-cadherin. Stem Cells 28(3): 564-572.
15. Goessler UR, Bugert P, Bieback K, et al. 2008; Integrin expression in stem cells from bone marrow and adipose tissue during chondrogenic differentiation. Int J Mol Med 21(3): 271-279.
16. Gomoll AH. 2012; Microfracture and augments. J Knee Surg 25(1): 9-15.
17. Guillotin B, Souquet A, Catros S, et al. 2010; Laser assisted bioprinting of engineered tissue with high cell density and microscale organization. Biomaterials 31(28): 7250-7256.
18. Hangody L, Vasarhelyi G, Hangody LR, et al. 2008; Autologous osteochondral grafting - technique and long-term results. Injury 39(SUPPL. 1): S32-39.
19. Hayes AJ, Hall A, Brown L, et al. 2007; Macromolecular organization and in vitro growth characteristics of scaffold-free neocartilage grafts. J Histochem Cytochem 55(8): 853-866.
20. Hu JC, Athanasiou KA. 2006; Chondrocytes from different zones exhibit characteristic differences in high density culture. Connect Tissue Res 47(3): 133-140.
21. Hutmacher DW. 2000; Scaffolds in tissue engineering bone and cartilage. Biomaterials 21(24): 2529-2543.
22. Hwang NS, Varghese S, Lee HJ, et al. 2007; Response of zonal chondrocytes to extracellular matrix hydrogels. FEBS Lett 581(22): 4172-4178.
23. Jeon JE, Schrobback K, Hutmacher DW, et al. 2012; Dynamic compression improves biosynthesis of human zonal chondrocytes from osteoarthritis patients. Osteoarthr Cartilage 20(8): 906-915.
24. Jia X, Kiick KL. 2009; Hybrid multicomponent hydrogels for tissue engineering. Macromol Biosci 9(2): 140-156.
25. Jin G, Howe PH. 1997; Regulation of clusterin gene expression by transforming growth factor-β. J Biol Chem 272(42): 26620-26626.
26. Khan IM, Salter DM, Bayliss MT, et al. 2001; Expression of clusterin in the superficial zone of bovine articular cartilage. Arthritis Rheum 44(8): 1795-1799.
27. Kim TK, Sharma B, Williams CG, et al. 2003; Experimental model for cartilage tissue engineering to regenerate the zonal organization of articular cartilage. Osteoarthr Cartilage 11(9): 653-664.
28. Klein TJ, Schumacher BL, Blewis ME, et al. 2006; Tailoring secretion of proteoglycan 4 (PRG4) in tissue-engineered cartilage. Tissue Eng 12(6): 1429-1439.
29. Lang M, Wang W, Chen X, et al. 2010; Integrated system for 3D assembly of bio-scaffolds and cells. In International Conference on Automation Science and Engineering (CASE), Toronto, Canada; 786-791.
30. Larson CM, Kelley SS, Blackwood AD, et al. 2002; Retention of the native chondrocyte pericellular matrix results in significantly improved matrix production. Matrix Biol 21(4): 349-359.
31. Lee CH, Cook JL, Mendelson A, et al. 2010; Regeneration of the articular surface of the rabbit synovial joint by cell homing: a proof of concept study. Lancet 376(9739): 440-448.
32. Lee DA, Noguchi T, Knight MM, et al. 1998; Response of chondrocyte subpopulations cultured within unloaded and loaded agarose. J Orthop Res 16(6): 726-733.
33. Lorenzo P, Bayliss MT, Heinegard D. 1998; A novel cartilage protein (CILP) present in the mid-zone of human articular cartilage increases with age. J Biol Chem 273(36): 23463-23468.
34. Malda J, ten Hoope W, Schuurman W, et al. 2010; Localization of the potential zonal marker clusterin in native cartilage and in tissue-engineered constructs. Tissue Eng Part A 16(3): 897-904.
35. Malda J, Woodfield TB, Van Der Vloodt F, et al. 2004; The effect of PEGT/PBT scaffold architecture on oxygen gradients in tissue engineered cartilaginous constructs. Biomaterials 25(26): 5773-5780.
36. Malda J, Woodfield TB, Van Der Vloodt F, et al. 2005; The effect of PEGT/PBT scaffold architecture on the composition of tissue engineered cartilage. Biomaterials 26(1): 63-72.
37. Melchels FPW, Domingos MNO, Klein TJ, et al. 2012; Additive manufacturing of tissues and organs. Progr Polym Sci 37(8): 1079-1104.
38. Miot S, Woodfield TBF, Daniels AU, et al. 2005; Effects of scaffold composition and architecture on human nasal chondrocyte redifferentiation and cartilaginous matrix deposition. Biomaterials 26(15): 2479-2489.
39. Mironov V, Boland T, Trusk T, et al. 2003; Organ printing: computer-aided jet-based 3D tissue engineering. Trends Biotechnol 21(4): 157-161.
40. Murphy BF, Kirszbaum L, Walker ID, et al. 1988; SP-40, 40, a newly identified normal human serum protein found in the SC5b-9 complex of complement and in the immune deposits in glomerulonephritis. J Clin Invest 81(6): 1858-1864.
41. Murray RC, Smith RK, Henson FM, et al. 2001; The distribution of cartilage oligomeric matrix protein (COMP) in equine carpal articular cartilage and its variation with exercise and cartilage deterioration. Vet J 162(2): 121-128.
42. Ng KW, Ateshian GA, Hung CT. 2009; Zonal chondrocytes seeded in a layered agarose hydrogel create engineered cartilage with depth-dependent cellular and mechanical inhomogeneity. Tissue Eng Part A 15(9): 2315-2324.
43. Peterson L, Brittberg M, Kiviranta I, et al. 2002; Autologous chondrocyte transplantation. Biomechanics and long-term durability. Am J Sports Med 30(1): 2-12.
44. Raizman I, De Croos JN, St-Pierre JP, et al. 2009; Articular cartilage subpopulations respond differently to cyclic compression in vitro. Tissue Eng Part A 15(12): 3789-3798.
45. Reddy KB, Jin G, Karode MC, et al. 1996; Transforming growth factor-β (TGFβ)-induced nuclear localization of apolipoprotein J/clusterin in epithelial cells. Biochemistry 35(19): 6157-6163.
46. Roh JD, Nelson GN, Udelsman BV, et al. 2007; Centrifugal seeding increases seeding efficiency and cellular distribution of bone marrow stromal cells in porous biodegradable scaffolds. Tissue Eng 13(11): 2743-2749.
47. Saris DB, Vanlauwe J, Victor J, et al. 2009; Treatment of symptomatic cartilage defects of the knee: characterized chondrocyte implantation results in better clinical outcome at 36 months in a randomized trial compared to microfracture. Am J Sports Med 37(SUPPL. 1): 10-19S.
48. Schagemann JC, Chung HW, Mrosek EH, et al. 2010; Poly(ε-caprolactone)/gel hybrid scaffolds for cartilage tissue engineering. J Biomed Mater Res A 93(2): 454-463.
49. Schmidt TA, Schumacher BL, Klein TJ, et al. 2004; Synthesis of proteoglycan 4 by chondrocyte subpopulations in cartilage explants, monolayer cultures, and resurfaced cartilage cultures. Arthritis Rheum 50(9): 2849-2857.
50. Schon BS, Schrobback K, van der Ven M, et al. 2012; Validation of a high-throughput microtissue fabrication process for 3D assembly of tissue engineered cartilage constructs. Cell Tissue Res 347(3): 629-642.
51. Schrobback K, Malda J, Crawford RW, et al. 2012; Effects of oxygen on zonal marker expression in human articular chondrocytes. Tissue Eng Part A 18(9-10): 920-933.
52. Schumacher BL, Block JA, Schmid TM, et al. 1994; A novel proteoglycan synthesized and secreted by chondrocytes of the superficial zone of articular cartilage. Arch Biochem Biophys 311(1): 144-152.
53. Schumacher BL, Hughes CE, Kuettner KE, et al. 1999; Immunodetection and partial cDNA sequence of the proteoglycan, superficial zone protein, synthesized by cells lining synovial joints. J Orthop Res 17(1): 110-120.
54. Schuurman W, Gawlitta D, Klein TJ, et al. 2009; Zonal chondrocyte subpopulations reacquire zone-specific characteristics during in vitro redifferentiation. Am J Sports Med 37(SUPPL. 1): 97-104S.
55. Schuurman W, Khristov V, Pot MW, et al. 2011; Bioprinting of hybrid tissue constructs with tailorable mechanical properties. Biofabrication 3(2): 021001.
56. Shahin K, Doran PM. 2011; Improved seeding of chondrocytes into polyglycolic acid scaffolds using semi-static and alginate loading methods. Biotechnol Prog 27(1): 191-200.
57. Sharma B, Williams CG, Kim TK, et al. 2007; Designing zonal organization into tissue-engineered cartilage. Tissue Eng 13(2): 405-414.
58. Sobral JM, Caridade SG, Sousa RA, et al. 2011; Three-dimensional plotted scaffolds with controlled pore size gradients: effect of scaffold geometry on mechanical performance and cell seeding efficiency. Acta Biomater 7(3): 1009-1018.
59. Steadman JR, Rodkey WG, Briggs KK, et al. 1999; The microfracture technique in the management of complete cartilage defects in the knee joint. Orthopade 28(1): 26-32.
60. Tallheden T, Bengtsson C, Brantsing C, et al. 2005; Proliferation and differentiation potential of chondrocytes from osteoarthritic patients. Arthritis Res Ther 7(3): R560-568.
61. Tuan RS. 2003; Cellular signaling in developmental chondrogenesis: N-cadherin, Wnts, and BMP-2. J Bone Joint Surg Am 85A(SUPPL. 2): 137-141.
62. Vanderploeg EJ, Wilson CG, Levenston ME. 2008; Articular chondrocytes derived from distinct tissue zones differentially respond to in vitro oscillatory tensile loading. Osteoarthr Cartilage 16(10): 1228-1236.
63. Wang Z, Kim JH, Higashino K, et al. 2011; Cartilage intermediate layer protein (CILP) regulation in intervertebral discs: the effect of age, degeneration, and BMP-2. Spine (Phila Pa 1976) 37: E203-208.
64. Wolf F, Candrian C, Wendt D, et al. 2008; Cartilage tissue engineering using pre-aggregated human articular chondrocytes. Eur Cell Mater 16: 92-99.
65. Woodfield TB, Guggenheim M, von Rechenberg B, et al. 2009a; Rapid prototyping of anatomically shaped, tissue-engineered implants for restoring congruent articulating surfaces in small joints. Cell Prolif 42(4): 485-497.
66. Woodfield TB, Malda J, de Wijn J, et al. 2004; Design of porous scaffolds for cartilage tissue engineering using a three-dimensional fiber-deposition technique. Biomaterials 25(18): 4149-4161.
67. Woodfield TB, Moroni L, Malda J. 2009b; Combinatorial approaches to controlling cell behaviour and tissue formation in 3D via rapid-prototyping and smart scaffold design. Comb Chem High Throughput Screen 12(6): 562-579.
68. Woodfield TB, Van Blitterswijk CA, De Wijn J, et al. 2005; Polymer scaffolds fabricated with pore-size gradients as a model for studying the zonal organization within tissue-engineered cartilage constructs. Tissue Eng 11(9-10): 1297-1311.
69. Woodfield TBF, Miot S, Martin I, et al. 2006; The regulation of expanded human nasal chondrocyte re-differentiation capacity by substrate composition and gas plasma surface modification. Biomaterials 27(7): 1043-1053.
70. Xiao YL, Riesle J, Van Blitterswijk CA. 1999; Static and dynamic fibroblast seeding and cultivation in porous PEO/PBT scaffolds. J Mater Sci Mater Med 10(12): 773-777.